JPH0523385A - Calcium phosphate cement - Google Patents

Calcium phosphate cement

Info

Publication number
JPH0523385A
JPH0523385A JP3182584A JP18258491A JPH0523385A JP H0523385 A JPH0523385 A JP H0523385A JP 3182584 A JP3182584 A JP 3182584A JP 18258491 A JP18258491 A JP 18258491A JP H0523385 A JPH0523385 A JP H0523385A
Authority
JP
Japan
Prior art keywords
calcium phosphate
cement
curing time
strength
fluoride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP3182584A
Other languages
Japanese (ja)
Inventor
Masahiro Hirano
昌弘 平野
Hiroyasu Takeuchi
啓泰 竹内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Materials Corp
Original Assignee
Mitsubishi Materials Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Materials Corp filed Critical Mitsubishi Materials Corp
Priority to JP3182584A priority Critical patent/JPH0523385A/en
Publication of JPH0523385A publication Critical patent/JPH0523385A/en
Withdrawn legal-status Critical Current

Links

Abstract

PURPOSE:To enhance strength and acid resistance, to reduce the irregularity of strength and to shorten a curing time by using a powder based on calcium phosphate cement composed of a specific composition rich in biocompatibility and a liquid containing specific fluoride as base materials. CONSTITUTION:Water containing fluoride selected from the group consisting of NaF, KF, NH4 and a mixture of them is mixed with a cement powder prepared by mixing alpha-type calcium tertiary phosphate and calcium secondary phosphate so that a Ca/P mol ratio becomes 1.40-1.498 and the resulting mixture is cured. By this method, acid resistance is enhanced and a curing time can be shortened.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、骨欠損部及び骨空隙部
充填材等の整形外科用セメント若しくは裏層、覆髄材等
の歯科用セメント等として利用可能なリン酸カルシウム
セメントに関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a calcium phosphate cement which can be used as an orthopedic cement such as a filling material for bone defects and bone voids, or a dental cement such as a backing layer and a pulp capping material.

【0002】[0002]

【従来の技術】水硬性リン酸カルシウムは、凝結硬化に
よって生体内の歯及び骨の主成分に近似した化合物に転
化するために、歯及び骨の修復材料として有用であり、
更には生体高分子や生体中の有害な有機物又は無機質イ
オンの吸着剤として有用なものであることが知られてい
る。
BACKGROUND OF THE INVENTION Hydraulic calcium phosphate is useful as a tooth and bone restorative material because it is converted into a compound similar to the main components of teeth and bones in the body by setting and hardening.
Further, it is known to be useful as an adsorbent for biopolymers and harmful organic substances or inorganic ions in the living body.

【0003】従来、前記水硬性リン酸カルシウムとして
は、特開昭59−88351号公報において硬化液とし
て、塩類及び希薄酸を組合せて使用するリン酸カルシウ
ムセメントが、また特開昭60−253454号公報に
おいて、不飽和カルボン酸重合体を含有する酸性溶液を
使用するリン酸カルシウムセメントが開示されている。
しかしながら、前記水硬性リン酸カルシウムにおいて
は、セメントの硬化が終了するまでは、硬化液の酸性が
強く、生体にかなりの刺激を及ぼすという問題があり、
更には、セメントの硬化終了後も未反応の酸の溶出によ
りpHが低下し、その結果として生体に刺激を与えると
いう問題もある。
Conventionally, as the hydraulic calcium phosphate, calcium phosphate cement, which uses a combination of salts and a dilute acid as a hardening liquid in JP-A-59-88351, is not disclosed in JP-A-60-253454. A calcium phosphate cement using an acidic solution containing a saturated carboxylic acid polymer is disclosed.
However, in the hydraulic calcium phosphate, until the hardening of the cement is completed, there is a problem that the acidity of the hardening liquid is strong and gives considerable irritation to the living body.
Further, there is a problem that the pH is lowered due to the elution of unreacted acid even after the hardening of the cement, resulting in irritation to the living body.

【0004】そこでかかる問題の解決のため、水により
硬化する水硬性リン酸カルシウムセメントが開発されて
いる(例えば、FC REPORT,vol.6(19
88),p.475〜480「バイオセラミックスとし
ての水硬性アパタイト」)。前記水により硬化する水硬
性リン酸カルシウムとしては、特開昭64−37445
号公報において、単に水と練和するのみで37℃にて、
10分程度で硬化する水硬性リン酸カルシウムセメント
が提案されている。前記水硬性リン酸カルシウムはpH
がほぼ中性であり、生体に対する刺激も少なく、従来の
水硬性リン酸カルシウムセメントの問題点を解消するも
のである。
Therefore, in order to solve such a problem, hydraulic calcium phosphate cement which is hardened by water has been developed (for example, FC REPORT, vol. 6 (19).
88), p. 475-480 "Hydraulic apatite as bioceramics"). The hydraulic calcium phosphate that is hardened by water is described in JP-A-64-37445.
In the publication, simply kneading with water at 37 ° C,
A hydraulic calcium phosphate cement that hardens in about 10 minutes has been proposed. The hydraulic calcium phosphate has a pH
It is almost neutral and causes less irritation to the living body, and solves the problems of conventional hydraulic calcium phosphate cement.

【0005】しかしながら、前記水硬性リン酸カルシウ
ムは、実用上やや硬化時間が長く、硬化体自体の耐酸性
が低いため、特に歯科用に用いた場合に劣化し、破壊す
る危険性が極めて高いという問題がある。
However, the above-mentioned hydraulic calcium phosphate has a problem that the curing time is rather long in practical use and the acid resistance of the cured product itself is low, so that the risk of deterioration and destruction particularly when used for dentistry is extremely high. is there.

【0006】[0006]

【発明が解決しようとする課題】従って本発明の目的
は、生体親和性に優れ、硬化時間が短く、且つ実用上十
分な強度を有し、耐酸性にも優れるリン酸カルシウムセ
メントを提供することにある。
SUMMARY OF THE INVENTION Therefore, an object of the present invention is to provide a calcium phosphate cement having excellent biocompatibility, short curing time, practically sufficient strength, and excellent acid resistance. ..

【0007】[0007]

【課題を解決するための手段】本発明によれば、α型第
3リン酸カルシウムと第2リン酸カルシウムとのCa/
Pモル比が1.40〜1.498である混合物を主成分
とする粉剤と、液剤とからなり、該液剤が、NaF、K
F、NH4F及びこれらの混合物からなる群より選択さ
れるフッ化物を含有することを特徴とするリン酸カルシ
ウムセメントが提供される。
According to the present invention, Ca / α-type tribasic calcium phosphate and dibasic calcium phosphate
A powder agent containing a mixture having a P molar ratio of 1.40 to 1.498 as a main component and a liquid agent, wherein the liquid agent is NaF or K.
There is provided a calcium phosphate cement characterized in that it contains a fluoride selected from the group consisting of F, NH 4 F and mixtures thereof.

【0008】以下本発明を更に詳細に説明する。The present invention will be described in more detail below.

【0009】本発明のリン酸カルシウムセメントにおい
て、粉剤の主成分として用いるα型第3リン酸カルシウ
ムと第2リン酸カルシウムとは、水の存在下にて反応
し、リン酸8カルシウムを生成し、硬化する成分であ
る。前記リン酸8カルシウムは、生体内で速やかにヒド
ロキシアパタイトに転化する成分である。前記第2リン
酸カルシウムとしては、市販の第2リン酸カルシウム2
水和物等を好ましく挙げることができる。また前記反応
は、pH6〜8で最も速やかに進行する。
In the calcium phosphate cement of the present invention, the α-type tribasic calcium phosphate and the dibasic calcium phosphate used as the main components of the powder are components which react in the presence of water to produce 8-calcium phosphate and harden. .. The 8-calcium phosphate is a component that is rapidly converted into hydroxyapatite in vivo. As the dicalcium phosphate, commercially available dicalcium phosphate 2
A hydrate and the like can be preferably mentioned. The reaction proceeds most rapidly at pH 6-8.

【0010】前記α型第3リン酸カルシウムと第2リン
酸カルシウムとの混合割合は、Ca/Pモル比で1.4
0〜1.498の範囲とする必要がある。前記Ca/P
モル比が1.40未満の場合には最高強度に劣り、1.
498を超えると、初期強度に劣るので前記範囲とする
必要がある。この際前記Ca/Pモル比が1.40〜
1.47の場合には初期強度に優れ、1.47〜1.4
98の場合には硬化後3日目程度に発現する最高強度に
優れる。
The mixing ratio of the α-type tribasic calcium phosphate and the dibasic calcium phosphate is 1.4 in terms of Ca / P molar ratio.
It must be in the range of 0 to 1.498. Ca / P
When the molar ratio is less than 1.40, the maximum strength is poor, and 1.
If it exceeds 498, the initial strength tends to be poor, so it is necessary to set it in the above range. At this time, the Ca / P molar ratio is 1.40.
In the case of 1.47, the initial strength is excellent and 1.47 to 1.4
In the case of 98, the maximum strength that develops on the 3rd day after curing is excellent.

【0011】本発明のリン酸カルシウムセメントにおい
ては、前記粉剤を硬化させるための液剤に、セメントの
硬化時間を短縮させ、且つセメントの硬化により生成す
るヒドロキシアパタイト中の水酸イオンを、フッ素イオ
ンにより置換して耐酸性を向上させるためにNaF、K
F、NH4F及びこれらの混合物からなる群より選択さ
れるフッ化物を含有させる必要がある。
In the calcium phosphate cement of the present invention, a liquid agent for hardening the powder is prepared by shortening the hardening time of the cement and replacing the hydroxide ion in the hydroxyapatite produced by hardening the cement with a fluorine ion. NaF, K to improve acid resistance
It is necessary to include a fluoride selected from the group consisting of F, NH 4 F and mixtures thereof.

【0012】前記フッ化物の配合割合は、液剤中の濃度
が、0.001モル/l〜1モル/lの範囲なるように
配合するのが好ましい。0.001モル/l未満の場合
には、硬化時間短縮の効果が得られず、1モル/lを超
えるとフッ素による生体への影響が生じるので好ましく
ない。
[0012] The mixing ratio of the above-mentioned fluoride is preferably such that the concentration in the liquid preparation is in the range of 0.001 mol / l to 1 mol / l. If it is less than 0.001 mol / l, the effect of shortening the curing time cannot be obtained, and if it exceeds 1 mol / l, fluorine affects the living body, which is not preferable.

【0013】本発明において前記フッ化物を含有させる
液剤の基材は、水で十分であるが、操作性をより向上さ
せるために、例えばコンドロイチン硫酸ナトリウムやヒ
アルロン酸ナトリウム等のムコ多糖類を、また硬化時間
を短縮するためにコハク酸ナトリウムや乳酸ナトリウム
等の水溶性ナトリウム塩類等を添加することもできる。
In the present invention, water is sufficient as the base material of the liquid agent containing the fluoride, but in order to improve the operability, mucopolysaccharides such as sodium chondroitin sulfate and sodium hyaluronate, Water-soluble sodium salts such as sodium succinate and sodium lactate may be added to shorten the curing time.

【0014】前記粉剤と液剤との配合割合は、重量比で
1.0〜3.0:1の範囲とするのが好ましい。前記粉
剤の配合割合が1.0未満の場合には、硬化に長時間を
要し、3.0を超えると練和時の操作性が低下するので
好ましくない。
The mixing ratio of the powder agent and the liquid agent is preferably in the range of 1.0 to 3.0: 1 by weight. If the mixing ratio of the powder is less than 1.0, it takes a long time to cure, and if it exceeds 3.0, the operability during kneading is deteriorated, which is not preferable.

【0015】また本発明のリン酸カルシウムセメントに
は、必要に応じて硫酸バリウム、次炭酸ビスマス、ヨ−
ドホルム等のX線造影剤;ヨ−ドホルム、クロルヘキシ
ジン等の抗菌剤等を添加して用いても良い。
Further, the calcium phosphate cement of the present invention may contain barium sulfate, bismuth subcarbonate, yo-yo, if necessary.
X-ray contrast agents such as doform; antibacterial agents such as iodoform and chlorhexidine may be added and used.

【0016】[0016]

【発明の効果】本発明のリン酸カルシウムセメントは、
生体親和性に富む特定組成のリン酸カルシウムセメント
を主成分とする粉剤と、特定のフッ化物を含有する液剤
とを基材としているため、生体親和性に優れ、高強度且
つ強度のばらつきが少なく、また硬化時間が短く、耐酸
性に優れる。また歯科用セメントとして用いた場合に
は、徐々に放出される溶存フッ素イオンによる虫歯予防
効果を有する。
The calcium phosphate cement of the present invention is
Since the base material is a powder agent containing calcium phosphate cement of a specific composition rich in biocompatibility as a main component, and a liquid agent containing a specific fluoride, it has excellent biocompatibility, high strength and little variation in strength, and Short curing time and excellent acid resistance. Further, when used as a dental cement, it has a caries preventive effect due to gradually released dissolved fluoride ions.

【0017】[0017]

【実施例】以下本発明を実施例及び比較例により、更に
詳細に説明するが、本発明はこれらに限定されるもので
はない。
EXAMPLES The present invention will be described in more detail with reference to Examples and Comparative Examples, but the present invention is not limited thereto.

【0018】[0018]

【参考例1】α型第3リン酸カルシウムと第2リン酸カ
ルシウム(和光純薬工業株式会社製;第2リン酸カルシ
ウム2水和物,特級)とをCa/Pモル比が1.40、
1.45、1.48、1.498になるようにそれぞれ
混合し、セメント粉剤を得た。次いで得られた粉剤10
0重量部と液剤として水60重量部とを、練和し、硬化
させた。また硬化時間及び得られたセメント硬化体の圧
縮強度を測定した。結果を表1に示す。硬化時間はJI
S R5201に準じ、また圧縮強度は、セメント硬化
体(7mmφ,14mmL)を人工体液に3日間浸漬した
後、取り出して濡れた状態でインストロン社製万能試験
機を使用して測定した。
Reference Example 1 α-type tribasic calcium phosphate and dibasic calcium phosphate (manufactured by Wako Pure Chemical Industries, Ltd .; dibasic calcium phosphate dihydrate, special grade) at a Ca / P molar ratio of 1.40,
Cement dusts were obtained by mixing them so as to be 1.45, 1.48 and 1.498, respectively. Then the obtained powder 10
0 parts by weight and 60 parts by weight of water as a liquid agent were kneaded and cured. Further, the curing time and the compressive strength of the obtained cement cured product were measured. The results are shown in Table 1. Curing time is JI
According to SR5201, the compressive strength was measured by immersing the cement hardened body (7 mmφ, 14 mmL) in the artificial body fluid for 3 days, and then taking it out and using a universal testing machine manufactured by Instron.

【0019】[0019]

【参考例2】α型第3リン酸カルシウムと第2リン酸カ
ルシウムとをCa/Pモル比1.33及び1.499と
した以外は、参考例1と同様にして硬化時間と圧縮強度
を測定した。結果を表1に示す。
Reference Example 2 The curing time and compressive strength were measured in the same manner as in Reference Example 1 except that the Ca / P molar ratios of α-type tribasic calcium phosphate and dibasic calcium phosphate were changed to 1.33 and 1.499. The results are shown in Table 1.

【0020】[0020]

【表1】 [Table 1]

【0021】[0021]

【実施例1〜3】α型第3リン酸カルシウムと第2リン
酸カルシウムとをCa/Pモル比が1.48となるよう
に混合したセメント粉剤100重量部に、液剤として表
2に示す濃度にて、表2に示すフッ化物を含む水60重
量部を混合して硬化させ、硬化時間及び圧縮強度を測定
した。結果を表2に示す。
Examples 1 to 3 100 parts by weight of cement dust prepared by mixing α-type tribasic calcium phosphate and dibasic calcium phosphate so that the Ca / P molar ratio was 1.48, at the concentration shown in Table 2 as a liquid agent, 60 parts by weight of water containing fluoride shown in Table 2 was mixed and cured, and the curing time and compressive strength were measured. The results are shown in Table 2.

【0022】[0022]

【表2】 [Table 2]

【0023】[0023]

【実施例4】α型第3リン酸カルシウムと第2リン酸カ
ルシウムとをCa/Pモル比が1.45となるように混
合したセメント粉剤100重量部に、NH4Fを含有す
る水(0.25モル/l)60重量部を液剤として混合
し、硬化させた。得られた硬化体を一定形状に成形した
成形体(20mmφ、10mmL)5個を、常時37
℃、pH3に調節したクエン酸水溶液に30日間浸漬し
た後、取り出して、直径をマイクロメーターを用いて精
密に測定して平均値を算出したところ19.85±0.
03mmであった。
Example 4 100 parts by weight of cement dust prepared by mixing α-type tricalcium phosphate and dicalcium phosphate in a Ca / P molar ratio of 1.45 was added to water containing NH 4 F (0.25 mol). / L) 60 parts by weight were mixed as a liquid agent and cured. Five molded bodies (20 mmφ, 10 mmL) obtained by molding the obtained cured body into a constant shape were always used.
After immersing in an aqueous citric acid solution adjusted to pH 3 at 30 ° C for 30 days, it was taken out and the diameter was precisely measured using a micrometer to calculate an average value of 19.85 ± 0.
It was 03 mm.

【0024】[0024]

【比較例1】フッ化物を含まない水を液剤とした以外
は、実施例4と同様にして硬化体を調製し、クエン酸水
溶液に浸漬した後、直径を測定したところ、19.53
±0.07mmであった。
[Comparative Example 1] A cured product was prepared in the same manner as in Example 4, except that water containing no fluoride was used as the liquid agent, and after dipping it in an aqueous citric acid solution, the diameter was measured.
It was ± 0.07 mm.

【0025】実施例4と比較例1との結果より、本発明
のリン酸カルシウムセメントが、耐酸性に優れているこ
とが判る。
From the results of Example 4 and Comparative Example 1, it can be seen that the calcium phosphate cement of the present invention has excellent acid resistance.

Claims (1)

【特許請求の範囲】 【請求項1】 α型第3リン酸カルシウムと第2リン酸
カルシウムとのCa/Pモル比が1.40〜1.498
である混合物を主成分とする粉剤と、液剤とからなり、
該液剤が、NaF、KF、NH4F及びこれらの混合物
からなる群より選択されるフッ化物を含有することを特
徴とするリン酸カルシウムセメント。
Claims: 1. A Ca / P molar ratio of α-type tribasic calcium phosphate and dibasic calcium phosphate is 1.40 to 1.498.
Consisting of a powder having a mixture as a main component and a liquid,
A calcium phosphate cement, characterized in that the solution contains a fluoride selected from the group consisting of NaF, KF, NH 4 F and mixtures thereof.
JP3182584A 1991-07-23 1991-07-23 Calcium phosphate cement Withdrawn JPH0523385A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3182584A JPH0523385A (en) 1991-07-23 1991-07-23 Calcium phosphate cement

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3182584A JPH0523385A (en) 1991-07-23 1991-07-23 Calcium phosphate cement

Publications (1)

Publication Number Publication Date
JPH0523385A true JPH0523385A (en) 1993-02-02

Family

ID=16120843

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3182584A Withdrawn JPH0523385A (en) 1991-07-23 1991-07-23 Calcium phosphate cement

Country Status (1)

Country Link
JP (1) JPH0523385A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000140089A (en) * 1998-07-31 2000-05-23 Merck Patent Gmbh Mixing method for calcium phosphate cement
ES2301320A1 (en) * 2005-12-15 2008-06-16 Faleh Tamimi Mariño Cement granules for bone regeneration, comprise calcium phosphate as basic component, acid of calcium phosphate, glycolic acid solution, and additive to control rheology and cohesion of cement

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000140089A (en) * 1998-07-31 2000-05-23 Merck Patent Gmbh Mixing method for calcium phosphate cement
ES2301320A1 (en) * 2005-12-15 2008-06-16 Faleh Tamimi Mariño Cement granules for bone regeneration, comprise calcium phosphate as basic component, acid of calcium phosphate, glycolic acid solution, and additive to control rheology and cohesion of cement

Similar Documents

Publication Publication Date Title
JP2621622B2 (en) Hydraulic calcium phosphate cement
JP2808410B2 (en) Curable composition and treating agent therefor
JPS6219508A (en) Root canal filling material for dental use
JPH0523386A (en) Calcium phosphate cement
JPH0523385A (en) Calcium phosphate cement
JP2006522641A (en) Premixed self-hardening bone graft paste
JP3965249B2 (en) Calcium phosphate cement and calcium phosphate cement composition
JPH059383B2 (en)
JP3000719B2 (en) Hydraulic calcium phosphate cement
JPH06172008A (en) Hardenable composition
JP3455551B2 (en) Hydraulic calcium phosphate cement hardening liquid
JPH03128062A (en) Water-curable type calcium phosphate cement composition
JPH03141955A (en) Hydraulic calcium phosphate cement setting fluid
JPH0360451A (en) Calcium phosphate hydraulic cement composition
JP2956251B2 (en) Calcium phosphate cement for living body
JPH0412044A (en) Hydraulic calcium phosphate cement composition
JP4319280B2 (en) Calcium phosphate cement powder and calcium phosphate cement composition
JPH01166763A (en) Medical and dental curable material
JPH07114804B2 (en) Medical curable composition
JP2830487B2 (en) Drug sustained release calcium phosphate cement
JPH0523387A (en) Calcium phosphate porous cement
JPH0335944B2 (en)
JPH0523388A (en) Calcium phosphate porous cement
JP2956250B2 (en) Calcium phosphate cement for living body
JPH0416539A (en) Hydraulic calcium phosphate cement composition

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 19981008